A Cleveland Clinic trial studies a 12-week web-based coaching program for those with psoriatic disease.Read More
A brief update on Zika for practicing rheumatologists in North America.
As advances in genomic medicine improve the diagnosis of autoinflammatory disease and help us recognize new disorders in this class, the need for coordinated care intensifies.
Subgroup analyses from the PRECISION trial allow rheumatologists to offer individualized treatment to OA and RA patients on chronic NSAIDs.
Rheumatologists eagerly await the day when we do not have to juggle protection against herpes zoster with the risks of giving a live vaccine to patients on high-dose prednisone and/or biologic DMARDs.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New therapies that harness the immune system to treat cancer are causing autoimmune inflammatory conditions in patients.
Uveitis accounts for 10-15 percent of legal blindness in the United States. At Cleveland Clinic, multicenter collaboration, fast-track evaluation and treatment help patients avoid vision loss.
Many patients with idiopathic recurrent pericarditis require prolonged glucocorticoids (GC), but GCs increase morbidity. Cleveland Clinic is studying alternative agents, including azathioprine, for these patients.
Cleveland Clinic’s osteoporosis and transplant centers have teamed up to implement a systematic approach to managing bone health in all transplant candidates, significantly decreasing the incidence of osteoporosis and improving quality of life.
Results of a small retrospective study on the use of immunosuppressive therapy show promise for preventing recurrent bleeding episodes in GAVE.
Our laboratory tests whether aberrant levels of plasma and tissue L-arginine metabolites serve as an early, non-invasive predictor of CV disease in psoriatic patients.